The Clinical Protocol and Data Management Shared Resource (CPDMSR) is a unifying administrative and educational organization of the San Antonio Cancer Institute that consolidates cancer clinical trials information and functions to meet needs defined by clinical investigators, external regulatory organizations, and individuals needing assistance in obtaining information about and/or referrals to SACI clinical trials. The CPDMSR offers the following services to investigator-members of SACI and to its affiliate institutions: Maintain a centralized library of active and closed cancer clinical trials from all affiliate member institutions of SACI; Publish quarterly a web-based catalog of all active cancer clinical trials for distribution to investigator-members and affiliates; Compile a real-time database of patient accrual to and demographic information for each protocol; Coordinate and perform auditing functions of the SACI including quality assurance audits of institutional studies and data and safety monitoring board (DSMB) meetings; Organize and present educational and training programs in data management, human subject research compliance, investigational drug accountability requirements, and other issues related to the conduct of clinical trials; Maintain a central contact office for external and internal inquiries about SACI cancer clinical trials, patient eligibility for specific studies, and referrals for clinical trial entry; and Assure that all investigators are in full compliance with regulatory issues, including: conflict of interest disclosures, 1572 submissions (for investigational drugs), IRB approvals of protocols, IACUC approvals, and education in human subjects certifications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA054174-12
Application #
6651729
Study Section
Project Start
2002-08-26
Project End
2003-07-31
Budget Start
Budget End
Support Year
12
Fiscal Year
2002
Total Cost
$254,104
Indirect Cost
Name
Ctrc Research Foundation
Department
Type
DUNS #
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Abbott, Jamie A; Meyer-Schuman, Rebecca; Lupo, Vincenzo et al. (2018) Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy. Hum Mutat 39:415-432
Guo, Jiayan; Kim, Hong Seok; Asmis, Reto et al. (2018) Interactions of ? tubulin isotypes with glutathione in differentiated neuroblastoma cells subject to oxidative stress. Cytoskeleton (Hoboken) 75:283-289
Liss, Michael A; Chen, Yidong; Rodriguez, Ronald et al. (2018) Immunogenic Heterogeneity of Renal Cell Carcinoma With Venous Tumor Thrombus. Urology :
Zhu, Haiyan; Xia, Lu; Shen, Qi et al. (2018) Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. Lab Invest 98:1384-1396
Zeno, Wade F; Baul, Upayan; Snead, Wilton T et al. (2018) Synergy between intrinsically disordered domains and structured proteins amplifies membrane curvature sensing. Nat Commun 9:4152
Mahalingam, Devalingam; Goel, Sanjay; Aparo, Santiago et al. (2018) A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma. Cancers (Basel) 10:
Yu, Xiaojie; Zhang, Yiqiang; Ma, Xiuye et al. (2018) miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer. Cancer Lett 427:85-93
Ankerst, Donna P; Goros, Martin; Tomlins, Scott A et al. (2018) Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator. Eur Urol Focus :
Arora, Sukeshi Patel; Mahalingam, Devalingam (2018) Immunotherapy in colorectal cancer: for the select few or all? J Gastrointest Oncol 9:170-179
Arellano, Luisa M; Arora, Sukeshi Patel (2018) Systemic Treatment of Advanced Hepatocellular Carcinoma in Older Adults. J Nat Sci 4:

Showing the most recent 10 out of 989 publications